Concurrent chemoradiotherapy for nasopharyngeal carcinoma

Concurrent chemoradiotherapy for nasopharyngeal carcinoma?

1. III Concurrent clinical trials have found that concurrent radiotherapy and chemotherapy can significantly improve the local control rate of patients with locally advanced nasopharyngeal carcinoma, significantly delay or prevent distant metastasis of nasopharyngeal carcinoma, and have a definite effect on improving survival rate. However, its toxicity cannot be ignored, especially for patients after induction chemotherapy, who cannot tolerate strong toxic side effects. It is recommended that while implementing induction chemotherapy, adjuvant chemotherapy or concurrent radiotherapy and chemotherapy, it should be combined with the combination of Chinese medicine to increase efficacy and reduce toxicity, which has a good synergistic effect on the treatment of nasopharyngeal carcinoma.

2. Compared with other drug treatments, chemotherapy is more effective for nasopharyngeal carcinoma, but it is also important to make plans based on the patient's specific physical condition. Friends in need can learn how nasopharyngeal carcinoma is treated with chemotherapy. Here is a brief introduction to the specific methods of nasopharyngeal carcinoma chemotherapy. Nasopharyngeal carcinoma is a malignant tumor disease with a high incidence rate, which can cause great harm to the patient's health.

How long can patients with advanced nasopharyngeal cancer live?

It also has a lot to do with personal constitution. The most important thing for patients with advanced cancer is to maintain a good attitude. Family members and friends should take good care of the patient's psychology and face their disease positively.

The survival time of advanced nasopharyngeal carcinoma is not fixed, which has a lot to do with the treatment method chosen by the patient. However, whether advanced nasopharyngeal carcinoma can live long-term also depends on the patient's condition, medical intervention or late metastasis.